Get the Stockscreener App
1.47
3.92%
-0.06
Mustang Bio Inc stock is traded at $1.47, with a volume of 177.96K.
It is down -3.92% in the last 24 hours and down -28.29% over the past month.
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
See More
Previous Close:
$1.53
Open:
$1.45
24h Volume:
177.96K
Relative Volume:
0.03
Market Cap:
$5.19M
Revenue:
-
Net Income/Loss:
$-23.42M
P/E Ratio:
-0.0188
EPS:
-78
Net Cash Flow:
$-16.67M
1W Performance:
-23.04%
1M Performance:
-28.29%
6M Performance:
-65.97%
1Y Performance:
-91.04%
1-Day Range:
$1.4211
$1.52
1-Week Range:
$1.4211
$1.96
52-Week Range:
$0.8926
$21.95
Mustang Bio Inc Stock (MBIO) Company Profile
Name
Mustang Bio Inc
Sector
Industry
Phone
(781) 652-4500
Address
377 PLANTATION STREET, WORCESTER, NY
Compare MBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MBIO
Mustang Bio Inc
|
1.47 | 6.70M | 0 | -23.42M | -16.67M | -78.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Mustang Bio Inc Stock (MBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-18-21 | Initiated | BTIG Research | Buy |
| Oct-02-20 | Initiated | B. Riley FBR | Buy |
| Nov-20-19 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-13-19 | Initiated | H.C. Wainwright | Buy |
| Jun-21-19 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-21-17 | Initiated | Oppenheimer | Outperform |
View All
Mustang Bio Inc Stock (MBIO) Latest News
Mustang Bio Inc.’s volatility index tracking explainedBuy Signal Forecast With Short-Term Data - Newser
Is Mustang Bio Inc. stock bottoming outFree Daily Stock Market Swing Alerts - Newser
Will Mustang Bio Inc. see short term momentumFree ROI Boosting Trade Opportunity Calendar - Newser
Analyzing recovery setups for Mustang Bio Inc. investorsIntraday Movement Recap and Chart Summary - Newser
Combining machine learning predictions for Mustang Bio Inc.Buy and Hold Strategy for Capital Safety - Newser
How Mustang Bio Inc. stock performs during market volatilityLong Term Stock Planner with Safety Checks - Newser
Published on: 2025-07-31 22:57:05 - Newser
What makes Mustang Bio Inc. stock price move sharplyVolume Spike Detection for Early Breakouts - Newser
Is Mustang Bio Inc. showing signs of accumulationIntraday Signal Forecast for Fast Traders - Newser
Using RSI to spot recovery in Mustang Bio Inc.AI-Based Reversal Point Prediction Signal - Newser
How to recover losses in Mustang Bio Inc. stockOversold Stock Bounce Playbook Generator - Newser
Why Mustang Bio Inc. stock attracts strong analyst attentionFree Short Term Setup With Predictive Chart - Newser
Will Mustang Bio Inc. stock go up soonFree Triple Digit Growth Focused Trade Plan - Newser
Sector Leaders Rotate Capital Into Mustang Bio Inc.Strong Buy With Technical Confidence Supported - metal.it
Reversal Traders Monitor Mustang Bio Inc. for EntryAI Powered High Return Stock Calls Dominate Watchlists - metal.it
Fibonacci Retracement Aligns with Support in Mustang Bio Inc.Fundamental Growth Stock Analysis Shows Strength - metal.it
Is It Too Late to Sell Mustang Bio Inc.Low Capital High Return Stock Plans Reviewed - metal.it
Trendlines Suggest Mustang Bio Inc. May Bottom Out SoonDaily Momentum Screener With Alerts Launched - metal.it
What institutional investors are buying Mustang Bio Inc. stockRapidly expanding wealth - jammulinksnews.com
Tick level data insight on Mustang Bio Inc. volatilityPredicted Market Direction Based on Momentum - Newser
Analyzing recovery setups for Mustang Bio Inc. investors Portfolio Risk Distribution Analysis Tool - Newser
Why is Mustang Bio Inc. stock attracting strong analyst attentionDiscover hidden gems in the stock market - jammulinksnews.com
Why Mustang Bio Inc. stock attracts strong analyst attention Expert-Backed High Yield Stock Watchlist - beatles.ru
Is Mustang Bio Inc. a growth stock or a value stockBuild wealth with high-performing stocks - jammulinksnews.com
When is Mustang Bio Inc. stock expected to show significant growthBuild wealth steadily with proven strategies - jammulinksnews.com
How does Mustang Bio Inc. generate profit in a changing economyExtraordinary earning power - jammulinksnews.com
What catalysts could drive Mustang Bio Inc. stock higher in 2025Capitalize on emerging trends for profits - jammulinksnews.com
What are the latest earnings results for Mustang Bio Inc.Breakthrough capital growth - jammulinksnews.com
Key External Factors That Drive Mustang Bio Inc. Stock Price MovementsSmart Money Signals - Newser
What analysts say about Mustang Bio Inc. stockMarket-crushing profits - PrintWeekIndia
Is Mustang Bio Inc. a good long term investmentConsistently high returns - PrintWeekIndia
Mustang Bio Inc. Stock Analysis and ForecastOutstanding stock performance - Autocar Professional
What drives Mustang Bio Inc. stock priceExceptional gains - jammulinksnews.com
Mustang Bio Inc Stock (MBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):